Connect Sign In
ARUP pairs analytical rigor with specialty expertise in immunopathology to provide reliable results, insights, and answers to complex diagnostic questions. Explore solutions with us at AMLI 2026.
ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes neoplastic populations with greater confidence and sensitivity, while minimizing specimen volume requirements.
Discover how ARUP is advancing laboratory medicine at ADLM 2026 through research presentations, expert insights, and innovative diagnostic solutions.
Cyclosporiasis cases are on the rise. ARUP’s AI-enhanced parasite screening offers greater sensitivity to detect Cyclospora and supports outbreak response efforts.
Tick activity has traditionally peaked during the warmer months but that seasonal window appears to be expanding. Changing climate patterns resulting in milder winters are allowing more ticks to survive, contributing to earlier emergence in the spring.
ARUP has launched multiplex polymerase chain reaction bacterial gastrointestinal panels that detect common pathogens with faster turnaround times to support rapid diagnosis and public health response.
Join ARUP experts at the American Society for Microbiology (ASM) Microbe 2026 conference for their latest research presentations, topic deep dives, and more.
Connect with ARUP experts to learn about our comprehensive neurology testing suites and how intentional lab testing can support clinically meaningful insights across a range of neurologic conditions.
The ARUP Consult Colorectal Cancer topic highlights updated screening recommendations and guidance to help clinicians choose appropriate tests for early detection.
ARUP research highlights include cytogenetic abnormalities of pediatric B-cell acute lymphoblastic leukemia, pharmacogenomic testing, and the influence of diet on biochemical genetic testing.
